BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31010844)

  • 1. The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
    Geldenhuys WJ; Nair RR; Piktel D; Martin KH; Gibson LF
    J Pharmacol Exp Ther; 2019 Jul; 370(1):25-34. PubMed ID: 31010844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the redox mitochondrial protein mitoNEET leads to mitochondrial dysfunction in B-cell acute lymphoblastic leukemia.
    Geldenhuys WJ; Piktel D; Moore JC; Rellick SL; Meadows E; Pinti MV; Hollander JM; Ammer AG; Martin KH; Gibson LF
    Free Radic Biol Med; 2021 Nov; 175():226-235. PubMed ID: 34496224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of miR-155 Promoting Drug Resistance in Childhood Acute Lymphoblastic Leukemia by Regulating Wnt/β-Catenin Signaling Pathway].
    Huang HM; Wei YJ; Wang D; Wen XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):418-424. PubMed ID: 35395973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia.
    Nair RR; Piktel D; Geldenhuys WJ; Gibson LF
    Leuk Res; 2018 Sep; 72():59-66. PubMed ID: 30103201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
    Wang Y; Han ZX; Zhang JC
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Establishment of Cytarabine-resistant Acute Lymphoblastic Leukemia Cell Lines and Its Resistance Mechanism].
    Qin X; Liu J; Chen X; Zhong FF; Yang Y; Zeng Y; Li C; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1403-1410. PubMed ID: 34627417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
    Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
    Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4.
    Sheikh-Zeineddini N; Safaroghli-Azar A; Salari S; Bashash D
    Eur J Pharmacol; 2020 Mar; 870():172821. PubMed ID: 31770526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Zittoun J; Marquet J; David JC; Maniey D; Zittoun R
    Cancer Chemother Pharmacol; 1989; 24(4):251-5. PubMed ID: 2752506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
    Avramis IA; Kwock R; Avramis VI
    Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACH2-mediated FOS confers cytarabine resistance via stromal microenvironment alterations in pediatric ALL.
    Zhang H; Zhang R; Zheng X; Sun M; Fan J; Fang C; Tian X; Zheng H
    Cancer Sci; 2021 Mar; 112(3):1235-1250. PubMed ID: 33393145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of
    Ma KP; Sun ZJ; Shen Y; Wang YQ; Lin DD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):50-56. PubMed ID: 36765476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS
    Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.
    Stam RW; van den Heuvel-Eibrink MM; den Boer ML; Ebus ME; Janka-Schaub GE; Allen JD; Pieters R
    Leukemia; 2004 Jan; 18(1):78-83. PubMed ID: 14574327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.
    Ristic B; Bosnjak M; Arsikin K; Mircic A; Suzin-Zivkovic V; Bogdanovic A; Perovic V; Martinovic T; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Exp Cell Res; 2014 Aug; 326(1):90-102. PubMed ID: 24907655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.